This Week in Startups E1022: One Drop CEO & Founder Jeff Dachis helps people with diabetes manage & improve their blood-sugar levels, shares insights on making data actionable, recent strategic partnership with Bayer, issues with US healthcare & potential life-expansion
Jan 28, 2020
In this insightful discussion, Jeff Dachis, CEO of OneDrop and a pioneer in digital health, shares his journey in transforming diabetes management. He reveals how OneDrop evolved from data collection to actionable insights, and discusses their strategic partnership with Bayer. Jeff tackles pressing issues in US healthcare, like the high cost of insulin, and the innovative potential of continuous glucose monitors. He envisions a future where health management could vastly improve and perhaps even extend human lifespan.
AI Snips
Chapters
Transcript
Episode notes
Apple Partnership Validation
- Getting One Drop's hardware into Apple stores validated consumer-driven healthcare.
- Apple's commitment to health and limited shelf space made the partnership a significant confidence boost.
Bayer Partnership
- Bayer invested $40 million in One Drop's Series B alongside a commercial licensing deal.
- A pre-existing relationship between Jeff Dachis and Bayer Pharmaceutical's CEO facilitated the partnership.
Post-Medication Management Gap
- Drug companies often lack systems for post-medication management and compliance.
- One Drop aims to bridge this gap by providing continuous feedback and support, unlike traditional healthcare.